CAS: 5989-77-5 - Dihydroergotamine Tartrate

Fórmula: C₃₇H₄₃N₅O₁₁

InChI: InChI=1S/C33H37N5O5.C4H6O6/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32;5-1(3(7)8)2(6)4(9)10/h3-6,8-11,17,21,23,25-27,34,42H,7,12-16,18H2,1-2H3,(H,35,39);1-2,5-6H,(H,7,8)(H,9,10)/t21-,23-,25-,26+,27+,32-,33+;1-,2-/m11/s1

Clave InChI: InChIKey=QCBGTQHGJQLHSY-ZQYJFMNESA-N

SMILES: O=C(O)C(O)C(O)C(=O)O.O=C(NC1(OC2(O)N(C1=O)C(C(=O)N3CCCC32)CC=4C=CC=CC4)C)C5CN(C)C6CC7=CNC8=CC=CC(=C87)C6C5

Sinónimos:

• 5'-Benzyl-12'-Hydroxy-2'-Methyl-3',6',18-Trioxo-9,10-Dihydroergotaman 2,3-Dihydroxybutanedioate (1:1)
• 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3′,6′,18-trione deriv.
• 9,10-Dihydroergotamine tartrate
• Bis(5'alpha-benzyl-9,10alpha-dihydro-12'-hydroxy-2'-methylergotaman-3',6',18-trione) (R-(R*,R*))-tartrate
• Dihydroergotamine tartrate (2:1)
• Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α,10α)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1)
• Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α,10α)-, (2R,3R)-2,3-dihydroxybutanedioate (2:1) (salt)
• Ergotaman-3′,6′,18-trione, 9,10-dihydro-12′-hydroxy-2′-methyl-5′-(phenylmethyl)-, (5′α,10α)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (2:1) (salt)
• Ergotamine, dihydro-, tartrate (2:1)(salt)
• Indolo[4,3-fg]quinoline, ergotaman-3′,6′,18-trione deriv.

Dihydroergotamine tartrate

CAS: 5989-77-5

• Fórmula: (C₃₃H₃₇N₅O₅)₂·C₄H₆O₆
• Peso molecular: 1317.44

Dihydroergotamine (+)-Tartrate Salt (2:1)

CAS: 5989-77-5

Applications Dihydroergotamine (+)-tartrate salt is a vascular serotonin receptor activator. In addition, it has been …

• Fórmula: (C₃₃H₃₇N₅O₅)•C₄H₆O₆
• Forma y color: White
• Peso molecular: 1317.44